Latest stories on NRXP
FDA Showdown Week: CAPR, NRXP, REPL And MRNA Face Make-Or-Break Regulatory Decisions
Stocktwits News50 · neutralgeneral
NRX Pharmaceuticals, Inc. (NRXP) files 8-K
SEC 8-K50 · neutralgeneral
Is NRx Pharmaceuticals, Inc. (NRXP) Stock Positioned for Growth Through Depression and PTSD Treatment Innovation?
Yahoo Finance56 · neutralanalyst
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute | NRXP Stock News
StockTitan50 · neutralgeneral
ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics
PR Newswire63 · neutralproduct/pr
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
Business Insider50 · neutralgeneral
NRx Pharmaceuticals (NRXP) Closes Underwritten Public Offering of Common Stock At $3.50 Per Share
Yahoo Top24 · bearishgeneral
NRx Pharmaceuticals Announces $20 Million Public Stock Offering
TipRanks24 · bearishgeneral
NRx Pharmaceuticals announces pricing of public offering of common stock
Seeking Alpha24 · bearishgeneral
NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock | NRXP Stock News
StockTitan24 · bearishgeneral
At a glance: stocks gapping down premarket
Seeking Alpha34 · bearishgeneral
NRx Pharmaceuticals announces proposed public stock offering
Seeking Alpha28 · bearishgeneral
NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock | NRXP Stock News
StockTitan24 · bearishgeneral
NRx Pharmaceuticals Earnings Call Maps 2026 Catalyst Path
TipRanks56 · neutralearnings
NRx Pharmaceuticals targets summer 2026 KETAFREE approval as it scales to 1M units per batch
Seeking Alpha67 · bullishproduct/pr
NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings